The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development

[31] Charlton B(1995)Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule Immunity 3 39-1040

[32] Gautam AM(2001)Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency N Engl J Med 345 1036-2152

[33] Noorchashm H(2009)Rituximab, B-lymphocyte depletion, and preservation of beta-cell function N Engl J Med 361 2143-707

[34] Noorchashm N(2009)Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes Nat Genet 41 703-3894

[35] Kern J(1994)Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development Mol Cell Biol 14 3884-1931

[36] Rostami SY(1997)CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes J Exp Med 186 1923-10

[37] Barker CF(1999)CD19 is a central response regulator of B lymphocyte signaling thresholds governing autoimmunity J Dermatol Sci 22 1-1462

[38] Naji A(2002)CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse J Clin Invest 109 1453-252

[39] Forsgren S(1998)Dendritic cells and the control of immunity Nature 392 245-363

[40] Andersson A(2013)Secondary T cell-T cell synaptic interactions drive the differentiation of protective CD8+ T cells Nat Immunol 14 356-402

[31] Charlton B(1995)Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule Immunity 3 39-1040

[32] Gautam AM(2001)Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency N Engl J Med 345 1036-2152

[33] Noorchashm H(2009)Rituximab, B-lymphocyte depletion, and preservation of beta-cell function N Engl J Med 361 2143-707

[34] Noorchashm N(2009)Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes Nat Genet 41 703-3894

[35] Kern J(1994)Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development Mol Cell Biol 14 3884-1931

[36] Rostami SY(1997)CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes J Exp Med 186 1923-10

[37] Barker CF(1999)CD19 is a central response regulator of B lymphocyte signaling thresholds governing autoimmunity J Dermatol Sci 22 1-1462

[38] Naji A(2002)CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse J Clin Invest 109 1453-252

[39] Forsgren S(1998)Dendritic cells and the control of immunity Nature 392 245-363

[40] Andersson A(2013)Secondary T cell-T cell synaptic interactions drive the differentiation of protective CD8+ T cells Nat Immunol 14 356-402